Position in DHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,196,326
+$71,720 QoQ
Shares Held
11,584
+24.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Derivatives in DHR
reported options exposure · as of Dec 31, 2025CallValue
$3,662,720
CallShares
16,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026J. Goldman & Co LP holds $6,499,746 across 3 Diagnostics & Research names. DHR ranks #2 (33.8% of the industry book) .
All Filings in DHR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,196,326 | 11,584 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,662,720 | 16,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $2,124,606 | 9,281 | Shares | Sole | 2026-02-17 | |
| 2022-09-30 | $2,623,451 | 10,157 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||